Literature DB >> 27862130

Reply.

James Hamilton1, Svetlana Lutsenko1.   

Abstract

Entities:  

Year:  2016        PMID： 27862130      PMCID： PMC5881165          DOI： 10.1002/hep.28938

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

1.  The level of serum lipids, vitamin E and low density lipoprotein oxidation in Wilson's disease patients.

Authors:  M Rodo; A Czonkowska; M Pulawska; M Swiderska; B Tarnacka; H Wehr
Journal:  Eur J Neurol       Date:  2000-09       Impact factor: 6.089

2.  Elevated copper impairs hepatic nuclear receptor function in Wilson's disease.

Authors:  Clavia Ruth Wooton-Kee; Ajay K Jain; Martin Wagner; Michael A Grusak; Milton J Finegold; Svetlana Lutsenko; David D Moore
Journal:  J Clin Invest       Date:  2015-08-04       Impact factor: 14.808

3.  The relationship between copper and steatosis in Wilson's disease.

Authors:  Mauro Liggi; Debora Murgia; Alberto Civolani; Enrico Demelia; Orazio Sorbello; Luigi Demelia
Journal:  Clin Res Hepatol Gastroenterol       Date:  2012-05-07       Impact factor: 2.947

4.  Alterations of lipid metabolism in Wilson disease.

Authors:  Jessica Seessle; Annina Gohdes; Daniel Nils Gotthardt; Jan Pfeiffenberger; Nicola Eckert; Wolfgang Stremmel; Ulrike Reuner; Karl Heinz Weiss
Journal:  Lipids Health Dis       Date:  2011-05-19       Impact factor: 3.876

5.  Activation of liver X receptor/retinoid X receptor pathway ameliorates liver disease in Atp7B(-/-) (Wilson disease) mice.

Authors:  James P Hamilton; Lahari Koganti; Abigael Muchenditsi; Venkata S Pendyala; David Huso; Joseph Hankin; Robert C Murphy; Dominik Huster; Uta Merle; Christopher Mangels; Nan Yang; James J Potter; Esteban Mezey; Svetlana Lutsenko
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.